MICROTECH MEDICAL (HANGZHOU) CO., LTD. Financials MicroTech Medical (Hangzhou) Co., Ltd.
Equities
2235
CNE100004QN6
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.03 HKD | -2.42% |
|
-1.23% | -37.03% |
| 27/03 | MicroTech Medical Co., Ltd. Appoints Shi Yonghui as Joint Company Secretary | CI |
| 27/03 | MicroTech Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 8,811 | 3,666 | 1,569 | 1,569 | - |
| Enterprise Value (EV) 1 | 6,660 | 1,620 | 571.6 | -111.9 | -49.27 |
| P/E ratio | -159 x | -108 x | -20.1 x | -18.6 x | -124 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 58.2 x | 21.1 x | 9.7 x | 4.29 x | 2.91 x |
| EV / Revenue | 44 x | 9.33 x | 2.26 x | -0.31 x | -0.09 x |
| EV / EBITDA | -121 x | -11.8 x | -2.9 x | 0.74 x | 0.69 x |
| EV / FCF | -108 x | - | 11.6 x | - | - |
| FCF Yield | -0.93% | - | 8.59% | - | - |
| Price to Book | 3.92 x | - | 0.72 x | - | - |
| Nbr of stocks (in thousands) | 4,25,743 | 4,25,743 | 4,21,079 | 4,21,079 | - |
| Reference price 2 | 20.70 | 8.611 | 3.727 | 3.727 | 3.727 |
| Announcement Date | 25/03/22 | 27/03/23 | 27/03/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 75.28 | 151.4 | 173.5 | 253.2 | 365.9 | 539.3 |
| EBITDA 1 | - | -55.2 | -137 | -197 | -151.8 | -71.35 |
| EBIT 1 | - | -58.94 | -140.4 | -200.1 | -166.6 | -90.13 |
| Operating Margin | - | -38.93% | -80.91% | -79% | -45.52% | -16.71% |
| Earnings before Tax (EBT) 1 | - | -48.15 | -35.04 | -124.9 | -83.1 | -13.41 |
| Net income 1 | - | -48.15 | -35.04 | -125 | -83.1 | -13.41 |
| Net margin | - | -31.8% | -20.19% | -49.37% | -22.71% | -2.49% |
| EPS 2 | - | -0.1300 | -0.0800 | -0.2900 | -0.2000 | -0.0300 |
| Free Cash Flow 1 | - | -61.82 | - | -32.66 | - | - |
| FCF margin | - | -40.83% | - | -12.97% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 26/09/21 | 25/03/22 | 27/03/23 | 27/03/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 59.41 | 91.99 | 71.82 | 101.7 | 110.8 | 142.4 | 156.4 | 209.4 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -28.73 | -30.24 | -46.7 | -93.71 | -65.89 | -134.2 | -59.74 | -106.8 |
| Operating Margin | -48.36% | -32.87% | -65.02% | -92.13% | -59.46% | -94.21% | -38.19% | -51% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
| Net income | - | - | -7.942 | - | - | - | - | - |
| Net margin | - | - | -11.06% | - | - | - | - | - |
| EPS 2 | - | - | -0.0200 | -0.0600 | -0.0400 | -0.2500 | -0.0400 | -0.1500 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 22/09/22 | 25/03/22 | 29/08/22 | 27/03/23 | 29/08/23 | 27/03/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 2,151 | 2,047 | 1,886 | 1,681 | 1,618 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -61.8 | - | -32.7 | - | - |
| ROE (net income / shareholders' equity) | - | -3.24% | - | -0.9% | - | - |
| ROA (Net income/ Total Assets) | - | -3.1% | - | -0.8% | - | - |
| Assets 1 | - | 1,553 | - | 4,342 | - | - |
| Book Value Per Share 2 | - | 5.280 | - | 5.150 | - | - |
| Cash Flow per Share | - | -0.1200 | - | - | - | - |
| Capex 1 | - | 17.6 | - | 50 | - | - |
| Capex / Sales | - | 11.62% | - | 19.85% | - | - |
| Announcement Date | 26/09/21 | 25/03/22 | 27/03/23 | 27/03/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
3.727
CNY
Average target price
5.266
CNY
Spread / Average Target
+41.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -37.03% | 217M | |
| +73.46% | 12.41B | |
| -15.61% | 8.23B | |
| +3.88% | 6.46B | |
| +14.69% | 5.5B | |
| -5.53% | 5.33B | |
| +42.58% | 5.1B | |
| -32.61% | 2.54B | |
| +10.80% | 1.99B | |
| -0.74% | 1.99B |
- Stock Market
- Equities
- 2235 Stock
- Financials MicroTech Medical (Hangzhou) Co., Ltd.